Skip to main content
News

Current FDA Watch List Includes Over 25 Drugs, Drug Classes

The FDA watch list, which provides new safety information or possible signs or serious illness, currently includes 27 drugs or drug classes. The current updated watch list, created from the FDA Adverse Event Reporting System, covers October 2017 through March 2018.

The current list includes 13 insulin pen products. According to the FDA, the insulin products are on the list due to incorrect use of the product by patients. The patients are not removing the inner needle cover, and the FDA is evaluating whether regulatory action regarding the products is needed.

Additional products on the list include 12 muscle relaxants. The agency found a potential risk for serotonin syndrome as well as too much nerve cell activity, which can lead to a potential array of deadly symptoms.

Lastly, the current list includes five forms of the commonly prescribed drug metformin used for the treatment of type 2 diabetes. Metformin was included on the list after multiple reports of serious skin reactions.

The FDA will evaluate whether regulatory actions is needed for many of the drugs on the current watch list. For some drugs, the potential risk has resulted in label changes. Notably, the FDA is not suggesting that these drugs are no longer prescribed or that patients stop taking them while potential safety problems are evaluated.  

The complete watch list is available on the FDA website.

—Julie Gould


For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here